公开(公告)号：WO2009079589A3

公开(公告)日：2009-08-20

申请号：PCT/US2008087242

申请日：2008-12-17

Applicant: NEW WORLD PHARMACEUTICALS LLC ,  SEXTON FREDERICK A ,  SUNI IAN IVAR ,  CETINKAYA CETIN ,  SCHUCKERS STEPHANIE ,  SAZONOV EDUARD

Inventor： SEXTON FREDERICK A ,  SUNI IAN IVAR ,  CETINKAYA CETIN ,  SCHUCKERS STEPHANIE ,  SAZONOV EDUARD

IPC: A61M5/00

CPC classification number: A61M5/1723 ,  A61B17/205 ,  A61M5/14276 ,  A61M5/158 ,  A61M37/0015 ,  A61M2005/14208 ,  A61M2005/1585 ,  A61M2037/0023 ,  A61M2037/003 ,  A61M2037/0038 ,  A61M2037/0061

Abstract: In one embodiment, an IDDC system utilizes an intelligent therapeutic agent delivery system comprised of one, but more likely an array of 'cells' containing therapeutic agent(s) and/or diagnostic agents(s); an integrated bio-sensing system designed to sample and analyze biological materials using multiple sensors that include both hardware and software components. The software component involves biomedical signal processing to analyze complex liquid mixtures and a microcontroller(s) acts as interface to the biosensors, to the therapeutic delivery elements, and to a communications system(s) for the purpose of controlling the amount of therapeutic agent to deliver and also to provide information in a useful form to interested parties on the progress of therapy and compliance thereto. The synergistic effect of combining the above describe elements is expected to dramatically improve patient compliance with prescribed therapy, quality and timeliness of care provided by physicians, and at the same time reduce the cost of providing effective healthcare to IDDC system users, thereby improving profitability for Managed Care organizations and pharmaceutical companies utilizing the system.

Abstract translation: 在一个实施方案中，IDDC系统利用智能治疗剂递送系统，该智能治疗剂递送系统由一个但更可能是含有治疗剂和/或诊断剂的“细胞”阵列组成; 一个集成的生物传感系统，设计用于使用包含硬件和软件组件的多个传感器对生物材料进行采样和分析。 软件组件涉及生物医学信号处理以分析复杂的液体混合物，并且微控制器充当生物传感器，治疗递送元件和通信系统的接口，以便将治疗剂的量控制为 提供并以有用的形式向感兴趣的各方提供关于治疗的进展和对其遵守的信息。 预计将上述描述元素相结合的协同作用可显着改善患者对规定治疗的依从性，医生提供的护理质量和及时性，同时降低向IDDC系统用户提供有效医疗保健的成本，从而提高 托管医疗机构和制药公司利用该系统。

公开(公告)号：WO2009079589A2

公开(公告)日：2009-06-25

申请号：PCT/US2008/087242

申请日：2008-12-17

Applicant: NEW WORLD PHARMACEUTICALS, LLC ,  SEXTON, Frederick, A. ,  SUNI, Ian, Ivar ,  CETINKAYA, Cetin ,  SCHUCKERS, Stephanie ,  SAZONOV, Eduard

Inventor： SEXTON, Frederick, A. ,  SUNI, Ian, Ivar ,  CETINKAYA, Cetin ,  SCHUCKERS, Stephanie ,  SAZONOV, Eduard

IPC: A61M5/00

CPC classification number: A61M5/1723 ,  A61B17/205 ,  A61M5/14276 ,  A61M5/158 ,  A61M37/0015 ,  A61M2005/14208 ,  A61M2005/1585 ,  A61M2037/0023 ,  A61M2037/003 ,  A61M2037/0038 ,  A61M2037/0061

Abstract: In one embodiment, an IDDC system utilizes an intelligent therapeutic agent delivery system comprised of one, but more likely an array of 'cells' containing therapeutic agent(s) and/or diagnostic agents(s); an integrated bio-sensing system designed to sample and analyze biological materials using multiple sensors that include both hardware and software components. The software component involves biomedical signal processing to analyze complex liquid mixtures and a microcontroller(s) acts as interface to the biosensors, to the therapeutic delivery elements, and to a communications system(s) for the purpose of controlling the amount of therapeutic agent to deliver and also to provide information in a useful form to interested parties on the progress of therapy and compliance thereto. The synergistic effect of combining the above describe elements is expected to dramatically improve patient compliance with prescribed therapy, quality and timeliness of care provided by physicians, and at the same time reduce the cost of providing effective healthcare to IDDC system users, thereby improving profitability for Managed Care organizations and pharmaceutical companies utilizing the system.

Abstract translation: 在一个实施方案中，IDDC系统利用智能治疗剂递送系统，其包括一个但更可能是包含治疗剂和/或诊断剂的“细胞”阵列; 一个集成的生物传感系统，旨在使用包含硬件和软件组件的多个传感器对生物材料进行采样和分析。 软件组件涉及生物医学信号处理以分析复杂的液体混合物，并且微控制器作为生物传感器，治疗递送元件和通信系统的界面，用于控制治疗剂的量 提供并向利害关系方提供有关治疗进展情况及其遵守情况的信息。 预期结合上述要素的协同效应将大大提高患者对规定治疗的依从性，医生提供的护理质量和及时性，同时降低向IDDC系统用户提供有效保健的成本，从而提高 管理保健组织和制药公司利用该系统。

公开(公告)号：WO2008072207A1

公开(公告)日：2008-06-19

申请号：PCT/IB2007/055098

申请日：2007-12-13

Applicant: L'AIR LIQUIDE-SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE ,  DONIAT, François ,  FISHER, Matthew L. ,  ZDUNEK, Alan D. ,  BARAJAS, Alejandro A. ,  SUNI, Ian ,  CHU, Xiangfeng ,  TRIPATHI, Abhinaz ,  LI, Yuzhuo

Inventor： DONIAT, François ,  FISHER, Matthew L. ,  ZDUNEK, Alan D. ,  BARAJAS, Alejandro A. ,  SUNI, Ian ,  CHU, Xiangfeng ,  TRIPATHI, Abhinaz ,  LI, Yuzhuo

IPC: C09G1/00 ,  H01L21/321

CPC classification number: C09G1/02 ,  C25F3/30 ,  H01L21/32125

Abstract: Compositions and methods suitable for the electrochemical mechanical planarization of a conductive material layer on a semiconductor workpiece. Compositions contain a phosphonic acid based electrolyte, a corrosion inhibitor, a chelating agent, a pH adjusting agent, and a solvent as the remainder.

Abstract translation: 适用于半导体工件上导电材料层的电化学机械平面化的组合物和方法。 组合物含有基于膦酸的电解质，腐蚀抑制剂，螯合剂，pH调节剂和作为其余的溶剂。